I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

We present the first reported case of *Aeromonas salmonicida* bacteremia in humans following chronic well water consumption. *Aeromonas* spp. bacteremia is more common in patients with immunocompromised conditions defined as cancer, liver cirrhosis, diabetes mellitus, end-stage renal disease, and receiving immunosuppressive therapy. We describe how *A. salmonicida* causes bacteremia and why physicians should ask about water sources when interviewing immunocompromised patients.

C[ASE]{.smallcaps} R[EPORT]{.smallcaps} {#sec1-2}
=======================================

A 62-year-old African-American male with diabetes (hemoglobin A1c 10.1% in 07/2016, +2.3% from 10/2015) with sarcoidosis and stage 3b chronic kidney disease (baseline creatinine 1.8--2.0 mg/dL) was admitted with right lower lobe (RLL) pneumonia and bacteremia. He drank wine socially but never used tobacco products or illicit drugs and lived on a rural property with private well water.

The week before admission, he was working on this property and drank lots of well water. He developed congestion and muscle soreness, followed by a productive cough with blood-streaked sputum, wheezing, and shortness of breath. He went to the closest emergency department. His temperature was 37.8°C, heart rate 104/min, respirations 20/min, blood pressure 167/78 mmHg, and oxygen saturation 93% on room air. Peripheral white blood cell (WBC) count was 2.9 K/μL with 80% polymorphonuclear leukocytes (PMNs). Basic metabolic profile revealed sodium 133 mmol/L, blood urea nitrogen (BUN) 39 mg/dL, creatinine 1.8 mg/dL, estimated glomerular filtration rate (eGFR) 38 mL/min/SA, and glucose 319 mg/dL. Chest X-ray \[[Figure 1](#F1){ref-type="fig"}\] read airspace disease with right lung base consolidation suggestive of acute lobar pneumonia. The patient left against medical advice and received a 10-day course of oral cefdinir 300 mg twice a day and methylprednisolone 4 mg 6-day taper. The following week, blood cultures taken from his recent ED visit grew nonlactose fermenting Gram-negative rods in the aerobic bottle; VITEK^®^ MS identified *A. salmonicida* sensitive to ampicillin, ampicillin/sulbactam, cefepime, ceftazidime, ceftriaxone, gentamicin, levofloxacin, meropenem, piperacillin/tazobactam, tobramycin, and trimethoprim-sulfamethoxazole and intermediate to cefazolin. He was admitted to our service for treatment of bacteremia and pneumonia.

![Chest X-ray, presentation](JGID-9-82-g001){#F1}

On admission, his temperature was 36.2°C, heart rate 72/min, respirations 18/min, blood pressure 158/56 mmHg, and oxygen saturation 95% on room air. He had rales in the RLL lobe with egophony and expiratory wheezing throughout lower lung lobes bilaterally, remainder of examination unremarkable. Peripheral WBC count was 12.8 K/μL with 89% PMNs. Complete metabolic profile remarkable for sodium 133 mmol/L, BUN 54 mg/dL, creatinine 2.28 mg/dL, eGFR 34 mL/min/SA, and glucose 648 mg/dL.

Given the unusual bacteria, we asked the patient about exposure to fish or other bodies of water: he had not been swimming, fishing, or boating for several decades; he ate store-bought fish 2 days after he went to the emergency department; and he drank well water at his property. We asked the laboratory at the referring hospital to repeat the patient\'s blood culture manually; using matrix-assisted laser desorption ionization time-of-flight technology, it grew the same *A. salmonicida* pathogen, reporting \>98% accuracy. Sputum cultures grew normal flora; bronchoscopy did not reveal other organisms or malignancy. Workup for an intra-abdominal source was negative: Patient\'s last colonoscopy in 2010 did not reveal masses, hepatitis panel was nonreactive, computed tomography of the chest/abdomen/pelvis \[[Figure 2](#F2){ref-type="fig"}\] was unremarkable, and barium swallow did not reveal aspiration. We began intravenous cefepime 2.0 g every 12 h. Two days after initiation of therapy, the patient\'s coughing improved without additional episodes of hemoptysis. Repeat blood cultures were negative, chest X-ray \[[Figure 3](#F3){ref-type="fig"}\] demonstrated resolution of RLL pneumonia. His acute-on-chronic kidney disease and hyperglycemia returned to baseline following fluid resuscitation and insulin. After 5 days of antibiotic therapy, his respiratory symptoms resolved completely, and he was discharged to home on a 10-day course of intravenous ceftriaxone 2.0 g/day.
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D[ISCUSSION]{.smallcaps} {#sec1-3}
========================

*A. salmonicida*, a Gram-negative nonlactose fermenting rod, is the bacterial pathogen responsible for furunculosis in salmonid Atlantic salmon and superficial ulcerative diseases in nonsalmonid carp (*Cyprinus carpio*), goldfish (*Carassius auratus*), and flounder (*Platichthys flesus*), and more lethal infections such as hemorrhagic septicemia in black-tip reef shark (*Carcharhinus melanopterus*).\[[@ref1][@ref2]\] Virulence factors -- outer protein coat and several pili -- are responsible for host colonization and subsequent bacteremia.\[[@ref3]\] *A. salmonicida* and other *Aeromonas* spp. have been isolated in surface water including salt water lagoons and beaches and fresh water wells.\[[@ref4][@ref5]\]

The incidence of *A. salmonicida* in humans is very rare. It was cultured from stool of patients with diarrheal diseases following ingestion of contaminated food.\[[@ref6]\] A patient with diabetes undergoing continuous ambulatory peritoneal dialysis developed *A. salmonicida* peritonitis after eating fish.\[[@ref7]\] To date, *A. salmonicida* bacteremia has not been reported. The most common species of *Aeromonas* associated with bacteremia are *A. hydrophila*, followed by *A. sobria*, *A. caviae*, and *A. veronii*.\[[@ref6]\] Tang *et al*. noticed 75% of *Aeromonas* spp. bacteremia involved patients with immunocompromised conditions defined as cancer, liver cirrhosis, diabetes, end-stage renal disease, or receiving immunosuppressive therapy.\[[@ref5]\] There are several reports of bacteremia due to *Aeromonas* spp. after water ingestion including one case of *A. hydrophila* bacteremia following years of well water consumption.\[[@ref8][@ref9]\] Chronic exposure of immunocompromised persons to *Aeromonas* through contaminated water can lead to invasive disease including bacteremia.\[[@ref10]\] Our patient had no underlying malignancies or liver cirrhosis and was not taking immunosuppressants; however, his diabetes had progressively worsened in the midst of chronic kidney disease and sarcoidosis. All of these factors, combined with his long-time exposure to *A. salmonicida* through well water, resulted in septicemia.

More importantly, complications from *Aeromonas* spp. bacteremia are significant: mortality rate is 33%, and relapse of septicemia is possible.\[[@ref6]\] It is critical to treat patients early with extended-spectrum cephalosporins, avoiding narrow-spectrum β-lactams as *Aeromonas* has inducible β-lactamase activity, and adding additional coverage with fluoroquinolones. Given that our patient had a quinolone allergy, we extended his course for 2 weeks total to provide additional coverage and avoid relapse.

This case suggests that *A. salmonicida* can cause bacteremia in immunocompromised individuals who chronically consume contaminated well water, and clinicians should consider water exposures in patients who present with *Aeromonas* spp. bacteremia then promptly treat to avoid increased medical expenditures related to managing serious illnesses.
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